An observational study in Pneumonia, Child and Prognosis, sponsored by Children's Hospital of Fudan University. Completed at 1 site in China. Open to participants aged 29 Days to 18 Years. Per ClinicalTrials.gov, last updated 2023-02-27.
Sponsored by Children's Hospital of Fudan University · Observational
In this study, investigators aimed to develop and validate a risk score to predict severe outcomes (e.g., mortality and ICU admission) in children who were admitted to the Children's Hospital of Fudan University between 2017 and 2022 due to community-acquired pneumonia (CAP). The objectives were as follows.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's enrollment of 6,000 is above the median of 203 across 688 observational studies indexed under Pneumonia.
Browse Pneumonia studies →Children's Hospital of Fudan University is the lead sponsor of 262 studies on the registry; 92 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This was a retrospective cohort study of children aged between > 29 days and 18 years old who were admitted to the Children's Hospital of Fudan University in Shanghai, China from January 1, 2017 to December 31, 2022. Children were enrolled if they were hospitalized with signs and symptoms of lower respiratory tract infection and radiographic evidence of pneumonia.
Exclusion Criteria:
Other: exposures of interest: epidemiological data, clinical characteristics, laboratory data, and chest radiographic reports
epidemiological data (e.g., age, sex, and residential area), clinical characteristics (e.g., fever, cough, and wheeze), laboratory data (e.g., white blood cell, c-reaction protein, and procalcitonin), and chest radiographic reports (e.g., X-ray, CT, and ultrasound)
in-hospital mortality
in-hospital mortality among children hospitalized with CAP
Time frame: from admission to discharge, an average of 7 days
admission to ICU
admission to a intensive care unit for over 24 hours
Time frame: from admission to discharge, an average of 7 days
septic shock
occurrence of septic shock during admission
Time frame: from admission to discharge, an average of 7 days
treatment for severe pneumonia
vasoactive agents, positive-pressure ventilation or chest drainage, or extracorporeal membrane oxygenation
Time frame: from admission to discharge, an average of 7 days
Plan to share: No
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Fudan University